Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 124 clinical trials
Catheter Ablation for Atrial Fibrillation in patientS With End-sTage Heart Failure and Eligibility for Heart Transplantation

CASTLE-HTx will determine if AF ablation has beneficial effects on mortality in patients with end stage HF who are eligible for HTx

ejection fraction
catheter ablation
fibrillation
primary prevention
heart transplantation
  • 0 views
  • 28 Sep, 2021
  • 1 location
Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation (DAPA-AF)

This is a multicenter trial to evaluate the impact of treatment with dapagliflozin versus placebo following catheter ablation of atrial fibrillation (AF) on the burden of AF during 12 months of

ejection fraction
catheter ablation
fibrillation
type 2 diabetes mellitus
diabetes
  • 0 views
  • 03 May, 2022
  • 5 locations
Evaluation of Proper Radiofrequency Catheter Ablation Strategy for the Patients Who Were Changed to Paroxysmal Atrial Fibrillation From Persistent Atrial Fibrillation

complications and side effect, thus non-drug therapy such as catheter ablation is developed. catheter ablation has been performed for 10years world-wide, and showed superior treatment outcome

  • 0 views
  • 23 Jan, 2021
  • 1 location
Hybrid AbLaTion of Atrial Fibrillation (HALT-AF)

A randomised controlled trial to assess the efficacy of staged hybrid ablation when compared with standard catheter ablation in patients with non-paroxysmal atrial fibrillation (AF)

Accepts healthy volunteers
  • 0 views
  • 16 Jun, 2022
Pulmonary Vein Isolation vs SHAM-pulmonary Vein Isolation for Symptomatic Relief in Patients With AF (PVI-SHAM-AF)

fibrillation by catheter ablation is one of the treatment pillars in the complex field of "better symptom control" based on current Guidelines. Catheter ablation of atrial fibrillation is based on electrical

radiofrequency ablation
pulmonary vein isolation
catheter ablation
fibrillation
cardioversion
  • 0 views
  • 24 Mar, 2022
  • 2 locations
Arrhythmogenic Substrate in Primary Cardiomyopathies and/or Channellopathies

This study assesses the value of arrhythmogenic substrate identification and elimination by catheter ablation to prevent recurrent ventricular arrhythmias and sudden cardiac death in a series of

idiopathic cardiomyopathy
catheter ablation
cardiomyopathy
fibrillation
arrhythmia
  • 21 views
  • 08 May, 2021
  • 1 location
Ripple Mapping Guided Ablation of Ischaemic Ventricular Tachycardia. (RIPPLE-VT)

The Ripple VT-1 Study is a prospective clinical trial that aims to investigate if catheter ablation of ventricular tachycardia in patients with ischaemic heart disease can be effectively

ischemic cardiomyopathy
secondary prevention
heart disease
coronary disease
arterial disease
  • 0 views
  • 10 Feb, 2022
  • 1 location
Antiarrhythmics or Ablation for Ventricular Tachycardia 2 (VANISH2)

A multicenter, randomized clinical trial to assess whether catheter ablation or antiarrhythmic drug therapy provides the most effective control of important clinical outcomes for patients with

  • 0 views
  • 27 Jan, 2022
  • 20 locations
Strategies in Patients Undergoing Repeat AF Ablation (TRAP-AF)

catheter ablation for recurrent AF.

fibrillation
catheter ablation
  • 0 views
  • 21 Mar, 2022
  • 1 location
Feasibility and Safety of Same Day Discharge afTer Atrial Fibrillation Ablation (FAST-AF)

Catheter ablation with pulmonary vein (PV) isolation is a commonly performed strategy employed for the treatment of atrial fibrillation. The conventional approach for post-procedure care has

fibrillation
atrial flutter
catheter ablation
  • 0 views
  • 27 Feb, 2022